benzofuran has been researched along with Uterine Cervical Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, HS; Abd El-Karim, SS | 1 |
| Cai, T; Li, J; Ming, P; Ning, Y; Tang, F; Tao, T; Xie, S | 1 |
2 other study(ies) available for benzofuran and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents.
Topics: Antineoplastic Agents; Apoptosis; Benzofurans; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Female; HeLa Cells; Humans; Hydrazones; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Pyrazoles; Structure-Activity Relationship; Thiazolidinediones; Uterine Cervical Neoplasms | 2019 |
A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.
Topics: Animals; Apoptosis; Benzofurans; Cell Line, Tumor; Cyclin A2; Cyclin-Dependent Kinase 2; Female; G1 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Structure; Phytotherapy; Plant Extracts; Protein Kinases; Signal Transduction; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |